My Watchlist Items
- No Watchlist
Veru Inc. (VERU)
13.38 -0.90999985(-6.3680887%)
Warning: count(): Parameter must be an array or an object that implements Countable in /home/cweb/public_html/wp-content/themes/setwood/single-stock.php on line 130
| Title | Name | Pay | Currency Pay | Gender | Year Born | Title Since |
|---|---|---|---|---|---|---|
| Executive Vice President of Strategy & Commercial | Mr. Phillip Kuhn | N/A | USD | male | N/A | N/A |
| Executive Vice President & Gen. Deputy Counsel | Mr. Philip R. Greenberg | N/A | USD | male | N/A | N/A |
| Executive Vice President for Medical Affairs | Dr. Robert H. Getzenberg Ph.D. | N/A | USD | N/A | N/A | |
| Executive Vice President of Corporation Devel. | Mr. Kevin J. Gilbert CPA, J.D. | N/A | USD | male | N/A | N/A |
| Executive Vice President, Gen. Counsel & Corporation Strategy | Mr. Michael J. Purvis | N/A | USD | male | N/A | N/A |
| Executive Director of Investor Relations & Corporation Communications | Mr. Samuel Fisch | N/A | USD | male | N/A | N/A |
| Chief Scientific Officer | Dr. K. Gary Barnette Ph.D. | 507010 | USD | 1968 | N/A | |
| Chief Financial Officer & Chief Admin. Officer | Ms. Michele Greco | 443720 | USD | female | 1959 | N/A |
| Vice Chairman & Chief Corporation Officer | Dr. Harry Fisch | 465020 | USD | 1959 | N/A | |
| Chairman, Pres & Chief Executive Officer | Dr. Mitchell S. Steiner F.A.C.S., M.D., F.A.C.S | 874600 | USD | 1961 | N/A |
| Symbol | Date | Rating | Rating Score | Rating Details |
|---|---|---|---|---|
| VERU | 20 May, 2022 | B+ | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| VERU | 19 May, 2022 | B+ | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| VERU | 18 May, 2022 | B+ | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| VERU | 17 May, 2022 | B+ | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| VERU | 16 May, 2022 | B+ | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| VERU | 13 May, 2022 | B+ | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| VERU | 12 May, 2022 | B+ | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| VERU | 11 May, 2022 | B+ | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| VERU | 10 May, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| VERU | 9 May, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| VERU | 6 May, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| VERU | 5 May, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| VERU | 4 May, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| VERU | 3 May, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| VERU | 29 April, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| VERU | 28 April, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| VERU | 27 April, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| VERU | 26 April, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| VERU | 25 April, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| VERU | 22 April, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| VERU | 21 April, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| VERU | 20 April, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| VERU | 19 April, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| VERU | 18 April, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| VERU | 15 April, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| VERU | 14 April, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| VERU | 13 April, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| VERU | 12 April, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| VERU | 11 April, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| VERU | 8 April, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| VERU | 7 April, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| VERU | 6 April, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| VERU | 5 April, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| VERU | 4 April, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| VERU | 1 April, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| VERU | 31 March, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| VERU | 30 March, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| VERU | 29 March, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| VERU | 28 March, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| VERU | 25 March, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| VERU | 24 March, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| VERU | 23 March, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| VERU | 22 March, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| VERU | 21 March, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| VERU | 18 March, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| VERU | 17 March, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| VERU | 16 March, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| VERU | 15 March, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| VERU | 14 March, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| VERU | 11 March, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| VERU | 10 March, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| VERU | 9 March, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| VERU | 8 March, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| VERU | 7 March, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| VERU | 4 March, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| VERU | 3 March, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| VERU | 2 March, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| VERU | 1 March, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| VERU | 28 February, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| VERU | 25 February, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| VERU | 24 February, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| VERU | 23 February, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| VERU | 22 February, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| VERU | 18 February, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| VERU | 17 February, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| VERU | 16 February, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| VERU | 15 February, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| VERU | 14 February, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| VERU | 11 February, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| VERU | 10 February, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| VERU | 9 February, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| VERU | 8 February, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| VERU | 7 February, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| VERU | 5 February, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| VERU | 4 February, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| VERU | 3 February, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| VERU | 2 February, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| VERU | 1 February, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| VERU | 31 January, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| VERU | 28 January, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| VERU | 27 January, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| VERU | 26 January, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| VERU | 25 January, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| VERU | 24 January, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| VERU | 21 January, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| VERU | 20 January, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| VERU | 19 January, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| VERU | 18 January, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| VERU | 14 January, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| VERU | 13 January, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| VERU | 12 January, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| VERU | 11 January, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| VERU | 10 January, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| VERU | 7 January, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| VERU | 6 January, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| VERU | 5 January, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| VERU | 4 January, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| VERU | 3 January, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| VERU | 31 December, 2021 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| VERU | 30 December, 2021 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
Warning: count(): Parameter must be an array or an object that implements Countable in /home/cweb/public_html/wp-content/themes/setwood/single-stock.php on line 255
| Holder | Shares | Date Reported | Change |
|---|---|---|---|
| 1 January, 1970 | |||
| 1 January, 1970 | |||
| 1 January, 1970 | |||
| 1 January, 1970 | |||
| 1 January, 1970 |
| Holder | Shares | Date Reported | Weight Percent |
|---|---|---|---|
| NEW YORK STATE COMMON RETIREMENT FUND | 37375 | 31 March, 2022 | N/A |
| DIMENSIONAL FUND ADVISORS LP | 111767 | 31 December, 2021 | N/A |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 48000 | 30 September, 2021 | N/A |
| iShares Micro-Cap ETF | 130224 | 31 August, 2020 | 0.05 |
| iShares Russell 2000 ETF | 1090150 | 31 August, 2020 | 0.01 |
| iShares Core S&P Total U.S. Stock Market ETF | 15251 | 31 August, 2020 | N/A |
| iShares Russell 2000 Growth ETF | 456038 | 31 August, 2020 | 0.01 |
| Vanguard Total Stock Market Index Fund | 3744510 | 31 August, 2020 | N/A |
| TIAA-CREF Equity Index Fund | 62696 | 31 July, 2020 | N/A |
| Vanguard Russell 2000 Index Fund | 61705 | 31 July, 2020 | 0.01 |
| Vanguard Institutional Total Stock Market Index Fund | 50532 | 31 July, 2020 | N/A |
| Fidelity NASDAQ Composite Index Fund | 43597 | 31 July, 2020 | N/A |
| Vanguard Russell 2000 Growth Index Fund | 40118 | 31 July, 2020 | 0.01 |
| Fidelity Series Total Market Index Fund | 38180 | 31 July, 2020 | N/A |
| GuideMark Small/Mid Cap Core Fund | 10022 | 31 July, 2020 | 0.04 |
| Vanguard Extended Market Index Fund | 618564 | 31 July, 2020 | N/A |
| Fidelity Extended Market Index Fund | 223498 | 31 July, 2020 | N/A |
| AMG Managers Emerging Opportunities Fund | 176846 | 31 July, 2020 | 0.36 |
| Schwab Small-Cap Index Fund | 106971 | 31 July, 2020 | 0.01 |
| EQ/2000 Managed Volatility Portfolio | 93887 | 31 July, 2020 | 0.01 |
| CREF Stock Account | 92299 | 31 July, 2020 | N/A |
| Fidelity Total Market Index Fund | 75080 | 31 July, 2020 | N/A |
| Vanguard US Equity Index Fund | 19408 | 31 July, 2020 | N/A |
| ATM Small Cap Managed Volatility Portfolio | 19197 | 31 July, 2020 | 0.01 |
| Pacific Select Small-Cap Index Portfolio | 16863 | 31 July, 2020 | 0.01 |
| Schwab Total Stock Market Index Fund | 15200 | 31 July, 2020 | N/A |
| John Hancock VIT - Small Cap Index | 15093 | 31 July, 2020 | 0.01 |
| 1290 VT Micro Cap Portfolio | 11753 | 31 July, 2020 | 0.02 |
| Vanguard Balanced Index Fund | 27777 | 31 July, 2020 | N/A |
| VALIC Co I Small Cap Index Fund | 24238 | 31 July, 2020 | 0.01 |
| Xtrackers Russell 2000 UCITS ETF | 23504 | 31 July, 2020 | 0.01 |
| Northern Small Cap Index Fund | 28404 | 30 June, 2020 | 0.01 |
| Voya VP Russell Small Cap Index Port | 17923 | 30 June, 2020 | 0.01 |
| TIAA-CREF Small Cap Blend Index Fund | 80103 | 30 June, 2020 | 0.01 |
| DFA U.S. Core Equity 1 Portfolio | 32722 | 30 April, 2020 | N/A |
| DFA U.S. Vector Equity Portfolio | 14000 | 30 April, 2020 | N/A |
| DFA U.S. Core Equity 2 Portfolio | 50478 | 30 April, 2020 | N/A |
| Symbol | Transaction Date | Reporting Cik | Securities Owned | Company Cik | Reporting Name | Acquistion Or Disposition | Form Type | Securities Transacted | Security Name | Link |
|---|---|---|---|---|---|---|---|---|---|---|
| VERU | 22 April, 2022 | 0001314913 | 200000 | 0000863894 | BARNETTE K GARY | A | 4 | 200000 | Common Stock Option | View |
| VERU | 22 April, 2022 | 0001566698 | 100000 | 0000863894 | Greco Michele | A | 4 | 100000 | Common Stock Option | View |
| VERU | 22 April, 2022 | 0001688984 | 200000 | 0000863894 | FISCH HARRY | A | 4 | 200000 | Common Stock Option | View |
| VERU | 22 April, 2022 | 0001276244 | 300000 | 0000863894 | STEINER MITCHELL SHUSTER | A | 4 | 300000 | Common Stock Option | View |
| VERU | 29 March, 2022 | 0001821960 | 5000 | 0000863894 | Hyun Grace | A | 4 | 5000 | Common Stock Option | View |
| VERU | 3 November, 2021 | 0001689094 | 70000 | 0000863894 | Eisenberger Mario | A | 4 | 70000 | Common Stock Option | View |
| VERU | 3 November, 2021 | 0001821960 | 55000 | 0000863894 | Hyun Grace | A | 4 | 55000 | Common Stock Option | View |
| VERU | 3 November, 2021 | 0001276244 | 360000 | 0000863894 | STEINER MITCHELL SHUSTER | A | 4 | 360000 | Common Stock Option | View |
| VERU | 3 November, 2021 | 0001314913 | 134800 | 0000863894 | BARNETTE K GARY | A | 4 | 134800 | Common Stock Option | View |
| VERU | 3 November, 2021 | 0001566698 | 128400 | 0000863894 | Greco Michele | A | 4 | 128400 | Common Stock Option | View |
| VERU | 3 November, 2021 | 0001404846 | 70000 | 0000863894 | Rankowitz Michael L | A | 4 | 70000 | Common Stock Option | View |
| VERU | 3 November, 2021 | 0001542419 | 70000 | 0000863894 | Lu Lucy | A | 4 | 70000 | Common Stock Option | View |
| VERU | 3 November, 2021 | 0001688984 | 133200 | 0000863894 | FISCH HARRY | A | 4 | 133200 | Common Stock Option | View |
| VERU | 17 August, 2021 | 0001542419 | 9800 | 0000863894 | Lu Lucy | A | 4 | 4800 | Common Stock | View |
| VERU | 16 June, 2021 | 0001688984 | 764025 | 0000863894 | FISCH HARRY | D | 4 | 100000 | Common Stock | View |
| VERU | 14 May, 2021 | 0001542419 | 70000 | 0000863894 | Lu Lucy | A | 4 | 70000 | Common Stock Option | View |
| VERU | 23 March, 2021 | 0001821960 | 5000 | 0000863894 | Hyun Grace | A | 4 | 5000 | Common Stock Option | View |
| VERU | 10 March, 2021 | 0001821960 | 14790 | 0000863894 | Hyun Grace | A | 4 | 3500 | Common Stock | View |
| VERU | 12 February, 2021 | 0001276244 | 190000 | 0000863894 | STEINER MITCHELL SHUSTER | D | 4 | 20000 | Common Stock | View |
| VERU | 16 December, 2020 | 0001276244 | 7184767 | 0000863894 | STEINER MITCHELL SHUSTER | D | 4 | 250000 | Common Stock | View |
| VERU | 16 December, 2020 | 0001314913 | 0 | 0000863894 | BARNETTE K GARY | D | 4 | 100000 | Common Stock | View |
| VERU | 13 November, 2020 | 0001566698 | 116359 | 0000863894 | Greco Michele | A | 4 | 116359 | Common Stock Option | View |
| VERU | 13 November, 2020 | 0001566698 | 109500 | 0000863894 | Greco Michele | A | 4 | 109500 | Common Stock Option | View |
| VERU | 13 November, 2020 | 0001276244 | 40000 | 0000863894 | STEINER MITCHELL SHUSTER | A | 4 | 40000 | Common Stock Option | View |
| VERU | 13 November, 2020 | 0001276244 | 360000 | 0000863894 | STEINER MITCHELL SHUSTER | A | 4 | 360000 | Common Stock Option | View |
| VERU | 13 November, 2020 | 0001821960 | 50000 | 0000863894 | Hyun Grace | A | 4 | 50000 | Common Stock Option | View |
| VERU | 13 November, 2020 | 0001314913 | 112500 | 0000863894 | BARNETTE K GARY | A | 4 | 112500 | Common Stock Option | View |
| VERU | 13 November, 2020 | 0001701862 | 75000 | 0000863894 | Socorro Jesus | A | 4 | 75000 | Common Stock Option | View |
| VERU | 13 November, 2020 | 0001689094 | 70000 | 0000863894 | Eisenberger Mario | A | 4 | 70000 | Common Stock Option | View |
| VERU | 13 November, 2020 | 0001688984 | 125117 | 0000863894 | FISCH HARRY | A | 4 | 125117 | Common Stock Option | View |
| VERU | 13 November, 2020 | 0001688984 | 105000 | 0000863894 | FISCH HARRY | A | 4 | 105000 | Common Stock Option | View |
| VERU | 13 November, 2020 | 0001404846 | 70000 | 0000863894 | Rankowitz Michael L | A | 4 | 70000 | Common Stock Option | View |
| VERU | 26 August, 2020 | 0001688984 | 864025 | 0000863894 | FISCH HARRY | A | 4 | 5000 | Common Stock | View |
| VERU | 24 August, 2020 | 0001566698 | 96178 | 0000863894 | Greco Michele | A | 4 | 5000 | Common Stock | View |
| VERU | 21 February, 2020 | 0001688984 | 859025 | 0000863894 | FISCH HARRY | A | 4 | 1000 | Common Stock | View |
| VERU | 20 February, 2020 | 0001688984 | 858025 | 0000863894 | FISCH HARRY | A | 4 | 1000 | Common Stock | View |
| VERU | 19 February, 2020 | 0001701862 | 32500 | 0000863894 | Socorro Jesus | A | 4 | 5000 | Common Stock | View |
| VERU | 19 December, 2019 | 0001701862 | 27500 | 0000863894 | Socorro Jesus | A | 4 | 5000 | Common Stock | View |
| VERU | 5 December, 2019 | 0001276244 | 7434767 | 0000863894 | STEINER MITCHELL SHUSTER | D | 4 | 16590 | Common Stock | View |
| VERU | 4 December, 2019 | 0001276244 | 7451357 | 0000863894 | STEINER MITCHELL SHUSTER | D | 4 | 8410 | Common Stock | View |
| VERU | 14 November, 2019 | 0001688984 | 102000 | 0000863894 | FISCH HARRY | A | 4 | 102000 | Common Stock Option | View |
| VERU | 14 November, 2019 | 0001688984 | 123552 | 0000863894 | FISCH HARRY | A | 4 | 123552 | Common Stock Option | View |
| VERU | 14 November, 2019 | 0001566698 | 114903 | 0000863894 | Greco Michele | A | 4 | 114903 | Common Stock Option | View |
| VERU | 14 November, 2019 | 0001566698 | 94800 | 0000863894 | Greco Michele | A | 4 | 94800 | Common Stock Option | View |
| VERU | 14 November, 2019 | 0001314913 | 105000 | 0000863894 | BARNETTE K GARY | A | 4 | 105000 | Common Stock Option | View |
| VERU | 14 November, 2019 | 0001314913 | 137808 | 0000863894 | BARNETTE K GARY | A | 4 | 137808 | Common Stock Option | View |
| VERU | 14 November, 2019 | 0001276244 | 350000 | 0000863894 | STEINER MITCHELL SHUSTER | A | 4 | 350000 | Common Stock Option | View |
| VERU | 14 November, 2019 | 0001701862 | 55000 | 0000863894 | Socorro Jesus | A | 4 | 55000 | Common Stock Option | View |
| VERU | 14 November, 2019 | 0001404846 | 55000 | 0000863894 | Rankowitz Michael L | A | 4 | 55000 | Common Stock Option | View |
| VERU | 14 November, 2019 | 0001689094 | 55000 | 0000863894 | Eisenberger Mario | A | 4 | 55000 | Common Stock Option | View |
| VERU | 7 November, 2019 | 0001276244 | 7463263 | 0000863894 | STEINER MITCHELL SHUSTER | D | 4 | 7382 | Common Stock | View |
| VERU | 6 November, 2019 | 0001276244 | 7470645 | 0000863894 | STEINER MITCHELL SHUSTER | D | 4 | 17618 | Common Stock | View |
| VERU | 11 October, 2019 | 0001276244 | 7488263 | 0000863894 | STEINER MITCHELL SHUSTER | D | 4 | 7897 | Common Stock | View |
| VERU | 10 October, 2019 | 0001276244 | 7496160 | 0000863894 | STEINER MITCHELL SHUSTER | D | 4 | 6600 | Common Stock | View |
| VERU | 9 October, 2019 | 0001276244 | 7502760 | 0000863894 | STEINER MITCHELL SHUSTER | D | 4 | 1339 | Common Stock | View |
| VERU | 4 October, 2019 | 0001276244 | 7504099 | 0000863894 | STEINER MITCHELL SHUSTER | D | 4 | 3829 | Common Stock | View |
| VERU | 3 October, 2019 | 0001276244 | 7507928 | 0000863894 | STEINER MITCHELL SHUSTER | D | 4 | 5260 | Common Stock | View |
| VERU | 2 October, 2019 | 0001276244 | 7513188 | 0000863894 | STEINER MITCHELL SHUSTER | D | 4 | 5075 | Common Stock | View |
| VERU | 6 September, 2019 | 0001276244 | 7518263 | 0000863894 | STEINER MITCHELL SHUSTER | D | 4 | 6890 | Common Stock | View |
| VERU | 5 September, 2019 | 0001276244 | 7525153 | 0000863894 | STEINER MITCHELL SHUSTER | D | 4 | 5610 | Common Stock | View |
| VERU | 4 September, 2019 | 0001276244 | 7530763 | 0000863894 | STEINER MITCHELL SHUSTER | D | 4 | 17500 | Common Stock | View |
| VERU | 3 September, 2019 | 0001688984 | 857025 | 0000863894 | FISCH HARRY | A | 4 | 10000 | Common Stock | View |
| VERU | 30 August, 2019 | 0001688984 | 847025 | 0000863894 | FISCH HARRY | A | 4 | 4000 | Common Stock | View |
| VERU | 29 August, 2019 | 0001688984 | 843025 | 0000863894 | FISCH HARRY | A | 4 | 7000 | Common Stock | View |
| VERU | 20 August, 2019 | 0001566698 | 91178 | 0000863894 | Greco Michele | A | 4 | 20000 | Common Stock | View |
| VERU | 12 August, 2019 | 0001701862 | 22500 | 0000863894 | Socorro Jesus | A | 4 | 10000 | Common Stock | View |
| VERU | 7 August, 2019 | 0001276244 | 7548263 | 0000863894 | STEINER MITCHELL SHUSTER | D | 4 | 30000 | Common Stock | View |
| VERU | 3 July, 2019 | 0001276244 | 7578263 | 0000863894 | STEINER MITCHELL SHUSTER | D | 4 | 20000 | Common Stock | View |
| VERU | 5 June, 2019 | 0001276244 | 7598263 | 0000863894 | STEINER MITCHELL SHUSTER | D | 4 | 20000 | Common Stock | View |
| VERU | 13 May, 2019 | 0001404846 | 55000 | 0000863894 | Rankowitz Michael L | A | 4 | 55000 | Common Stock Option | View |
| VERU | 13 May, 2019 | 0001566698 | 92100 | 0000863894 | Greco Michele | A | 4 | 92100 | Common Stock Option | View |
| VERU | 13 May, 2019 | 0001314913 | 99000 | 0000863894 | BARNETTE K GARY | A | 4 | 99000 | Common Stock Option | View |
| VERU | 13 May, 2019 | 0001701862 | 55000 | 0000863894 | Socorro Jesus | A | 4 | 55000 | Common Stock Option | View |
| VERU | 13 May, 2019 | 0001276244 | 215600 | 0000863894 | STEINER MITCHELL SHUSTER | A | 4 | 215600 | Common Stock Option | View |
| VERU | 13 May, 2019 | 0001689094 | 55000 | 0000863894 | Eisenberger Mario | A | 4 | 55000 | Common Stock Option | View |
| VERU | 13 May, 2019 | 0001688984 | 99000 | 0000863894 | FISCH HARRY | A | 4 | 99000 | Common Stock Option | View |
| VERU | 1 May, 2019 | 0001276244 | 7618263 | 0000863894 | STEINER MITCHELL SHUSTER | D | 4 | 20000 | Common Stock | View |
| VERU | 10 April, 2019 | 0001276244 | 7638263 | 0000863894 | STEINER MITCHELL SHUSTER | D | 4 | 7686 | Common Stock | View |
| VERU | 5 April, 2019 | 0001276244 | 7645949 | 0000863894 | STEINER MITCHELL SHUSTER | D | 4 | 10100 | Common Stock | View |
| VERU | 4 April, 2019 | 0001276244 | 7656049 | 0000863894 | STEINER MITCHELL SHUSTER | D | 4 | 5854 | Common Stock | View |
| VERU | 3 April, 2019 | 0001276244 | 7661903 | 0000863894 | STEINER MITCHELL SHUSTER | D | 4 | 6360 | Common Stock | View |
| VERU | 26 March, 2019 | 0001689094 | 5000 | 0000863894 | Eisenberger Mario | A | 4 | 5000 | Common Stock Option | View |
| VERU | 20 March, 2019 | 0001276244 | 7668263 | 0000863894 | STEINER MITCHELL SHUSTER | D | 4 | 49899 | Common Stock | View |
| VERU | 15 March, 2019 | 0001688984 | 836025 | 0000863894 | FISCH HARRY | A | 4 | 3000 | Common Stock | View |
| VERU | 13 March, 2019 | 0001688984 | 833025 | 0000863894 | FISCH HARRY | A | 4 | 3500 | Common Stock | View |
| VERU | 6 March, 2019 | 0001688984 | 829525 | 0000863894 | FISCH HARRY | A | 4 | 3000 | Common Stock | View |
| VERU | 5 March, 2019 | 0001688984 | 826525 | 0000863894 | FISCH HARRY | A | 4 | 3500 | Common Stock | View |
| VERU | 1 March, 2019 | 0001276244 | 7714666 | 0000863894 | STEINER MITCHELL SHUSTER | D | 4 | 3496 | Common Stock | View |
| VERU | 28 February, 2019 | 0001276244 | 7718162 | 0000863894 | STEINER MITCHELL SHUSTER | D | 4 | 1500 | Common Stock | View |
| VERU | 27 February, 2019 | 0001688984 | 823025 | 0000863894 | FISCH HARRY | A | 4 | 3400 | Common Stock | View |
| VERU | 26 February, 2019 | 0001688984 | 819625 | 0000863894 | FISCH HARRY | A | 4 | 5000 | Common Stock | View |
| VERU | 25 February, 2019 | 0001688984 | 814625 | 0000863894 | FISCH HARRY | A | 4 | 3000 | Common Stock | View |
| VERU | 22 February, 2019 | 0001688984 | 811625 | 0000863894 | FISCH HARRY | A | 4 | 6000 | Common Stock | View |
| VERU | 21 February, 2019 | 0001688984 | 805625 | 0000863894 | FISCH HARRY | A | 4 | 5000 | Common Stock | View |
| VERU | 19 February, 2019 | 0001688984 | 800625 | 0000863894 | FISCH HARRY | A | 4 | 5000 | Common Stock | View |
| VERU | 15 February, 2019 | 0001688984 | 795625 | 0000863894 | FISCH HARRY | A | 4 | 13681 | Common Stock | View |
| VERU | 13 February, 2019 | 0001276244 | 7719662 | 0000863894 | STEINER MITCHELL SHUSTER | D | 4 | 4650 | Common Stock | View |
| VERU | 8 February, 2019 | 0001276244 | 7724312 | 0000863894 | STEINER MITCHELL SHUSTER | D | 4 | 6955 | Common Stock | View |
| VERU | 7 February, 2019 | 0001276244 | 7731267 | 0000863894 | STEINER MITCHELL SHUSTER | D | 4 | 300 | Common Stock | View |
| VERU | 6 February, 2019 | 0001276244 | 7731567 | 0000863894 | STEINER MITCHELL SHUSTER | D | 4 | 3200 | Common Stock | View |
Charts
Company Historical Earnings
| Date | Symbol | EPS | EPS Estimated | Time | Revenue | Revenue Estimated |
|---|---|---|---|---|---|---|
| 12 May, 2022 | VERU | -0.18 | -0.18 | bmo | 13028394 | 12320000 |
| 9 February, 2022 | VERU | -0.08 | -0.08 | bmo | 14135132 | 13000000 |
| 2 December, 2021 | VERU | -0.05 | -0.05 | bmo | 15646460 | 13000000 |
| 12 August, 2021 | VERU | -0.03 | -0.03 | bmo | 17655592 | 14100000 |
| 12 May, 2021 | VERU | -0.04 | -0.04 | bmo | 13340487 | 13340487 |
| 10 February, 2021 | VERU | 0.23 | 0.23 | bmo | 14616989 | 76739192 |
| 9 December, 2020 | VERU | -0.01 | -0.01 | bmo | 11749186 | 0 |
| 13 August, 2020 | VERU | -0.05 | -0.05 | bmo | 10321754 | 8515446.75 |
| 13 May, 2020 | VERU | -0.01 | -0.01 | bmo | 9943104 | 39772400 |
| 12 February, 2020 | VERU | -0.05 | -0.05 | bmo | 10578016 | 4231208 |
| 12 December, 2019 | VERU | -0.05 | -0.05 | bmo | 8728403 | 8728400 |
| 8 August, 2019 | VERU | -0.04 | -0.04 | bmo | 9727060 | 9727060 |
| 15 May, 2019 | VERU | -0.06 | -0.06 | bmo | 6976115 | 6976120 |
| 13 February, 2019 | VERU | -0.03 | -0.03 | bmo | 6371809 | 8495746.6666667 |
| 13 December, 2018 | VERU | -0.14 | -0.14 | bmo | 5203268 | 2973297.1428571 |
| 14 August, 2018 | VERU | -0.15 | -0.15 | bmo | 5501730 | 3829715.4375 |
| 9 May, 2018 | VERU | -0.07 | -0.07 | bmo | 2572872 | 1835714.2857143 |
| 14 February, 2018 | VERU | -0.08 | -0.08 | bmo | 2586613 | 971250 |
| 2 January, 2018 | VERU | -0.09 | -0.09 | bmo | 3692406 | 3601047.375 |
| 8 August, 2017 | VERU | -0.03 | -0.03 | bmo | 4314068 | 11493333.333333 |
| 9 May, 2017 | VERU | bmo | 2405519 | 0 | ||
| 9 February, 2017 | VERU | bmo | 3243599 | 0 | ||
| 12 December, 2016 | VERU | bmo | 3563106 | 0 | ||
| 28 July, 2016 | VERU | bmo | 5560776 | 0 | ||
| 28 April, 2016 | VERU | bmo | 4772801 | 0 | ||
| 2 February, 2016 | VERU | bmo | 8230659 | 0 | ||
| 1 December, 2015 | VERU | bmo | 7154985 | 0 | ||
| 30 July, 2015 | VERU | bmo | 7813207 | 0 | ||
| 30 April, 2015 | VERU | 0.06 | 0.06 | bmo | 10977467 | 12810000 |
| 3 February, 2015 | VERU | 0.03 | 0.03 | bmo | 6659206 | 15540000 |
| 2 December, 2014 | VERU | -0.02 | -0.02 | bmo | 5554113 | 5550000 |
| 31 July, 2014 | VERU | 0.04 | 0.04 | bmo | 7900055 | 9875000 |
| 1 May, 2014 | VERU | 0.01 | 0.01 | bmo | 4346223 | 8700000 |
| 3 February, 2014 | VERU | 0.05 | 0.05 | bmo | 6690195 | 6690000 |
| 3 December, 2013 | VERU | 0.23 | 0.23 | bmo | 4789187 | 2915652.173913 |
| 1 August, 2013 | VERU | 0.03 | 0.03 | bmo | 7280498 | 19413333.333333 |
| 2 May, 2013 | VERU | 0.12 | 0.12 | bmo | 9476866 | 6320000 |
| 12 September, 1997 | VERU | -0.11 | -0.11 | bmo | 800000 | 0 |
| 19 May, 1997 | VERU | -0.22 | -0.22 | bmo | 600000 | 600000 |
| 9 January, 1997 | VERU | -0.63 | -0.63 | bmo | 600000 | 556871.625 |
| 3 August, 1994 | VERU | -0.04 | -0.04 | bmo | 5400000 | 9720000 |
Company Profile
Company Name Veru Inc.
Symbol VERU
Currency USD
Price 13.38
Exchange Name NASDAQ Capital Market (NASDAQ)
Industry Biotechnology
Website https://www.verupharma.com
CEO Dr. Mitchell Steiner
Sector Healthcare
Country US
Full Time Employees 252
Phone 13125959123
Address 48 NW 25th St Ste 102
City Miami
State FLORIDA
Zip 33127
Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N. agencies, nonprofit organizations, and commercial partners. The company's development drug candidates include Enobosarm, an oral selective androgen receptor agonist that is in phase III clinical trial for the treatment of AR+ ER+ HER2- metastatic breast cancer; Sabizabulin, which is phase IIb clinical trial for the treatment of AR+ ER+ HER2- metastatic breast cancer; Enobosarm + abemaciclib combination therapy, which is in phase III clinical trial for the treatment of AR+ ER+ HER2- metastatic breast cancer; and Sabizabulin + enobosarm combination therapy, an oral targeted cytoskeleton disruptor plus selective androgen receptor agonist, which is in phase II clinical trial for the treatment of metastatic triple negative breast cancer. Its drug candidates also comprise Sabizabulin, which is in Phase II clinical trial for the treatment of metastatic castration and androgen receptor targeting agent resistant prostate cancer; VERU-100, a GnRH antagonist peptide injection, which is in Phase II clinical trial for the treatment of advanced hormone sensitive prostate cancer; Zuclomiphene Citrate, which is in Phase II clinical trial for treating hot flashes; and Sabizabulin, which is in phase III clinical trial for the treatment of SARS-CoV-2 in subjects at high risk for acute respiratory distress syndrome. In addition, the company is advancing a new drug formulation for the treatment of men with lower urinary tract symptoms from an enlarged prostate. The company was formerly known as The Female Health Company and changed its name to Veru Inc. in July 2017. Veru Inc. was incorporated in 1971 and is headquartered in Miami, Florida.
